Cerus Corp. (CERS)
2.70
+0.27
(+11.11%)
USD |
NASDAQ |
May 19, 16:00
2.695
0.00 (0.00%)
After-Hours: 20:00
Cerus Research and Development Expense (Quarterly) : 14.53M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merit Medical Systems, Inc. | 22.61M |
| ResMed, Inc. | 94.27M |
| Stryker Corp. | 404.00M |
| Abbott Laboratories | 767.00M |
| AngioDynamics, Inc. | 7.084M |